Bioceres (BIOX) and the Colorado Wheat Research Foundation announced a strategic collaboration to jointly develop and commercialize HB4 wheat in the United States. The agreement combines Bioceres’ proprietary HB4 technology, with CWRF’s U.S. wheat innovation to create a wheat production system. This system is designed to integrate climate resilience and environmentally responsible weed management, delivering greater productivity for growers and improved supply stability for customers. As part of the collaboration, Bioceres will grant CWRF exclusive, sublicensable rights to the HB4 trait in the U.S. territory. CWRF will serve as trait manager, facilitating broad access to HB4 wheat for third-party breeding programs and commercial channels, and leading engagement with U.S. stakeholders. The parties will also work together with industry participants to develop, register, and commercialize new broad-spectrum herbicide formulations tailored for HB4 wheat.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BIOX:
- Bioceres price target lowered to $5 from $8 at Lake Street
- Bioceres downgraded to Hold from Buy at Canaccord
- Bioceres Crop Solutions: Hold Rating Amid Macroeconomic Challenges and Strategic Shift
- Bioceres Crop Solutions Faces Challenging Fiscal Year
- Bioceres Crop Solutions Earnings Call Highlights Challenges and Recovery